FindTrial
Sign In

Mysimba 8 mg/90 mg prolonged-release tablets

DRUG2 trials

Sponsors

Zuyderland Medisch Centrum Stichting, Sint Franciscus Vlietland Groep Stichting

Conditions

ObesityObesity SurgeryPeople with a Body Mass Index (BMI) of 30 kg/m2 or more (obese)dislipidaemia or regulated hypertension)or 27 kg/m2 to 30 kg/m2 in the presence of one or more weight-related comorbidities (e.g. type 2 diabetes

Phase 3

Applying Mysimba in patients with weight regain after bariatric surgery
Not yet recruitingCTIS2024-516645-39-01
Zuyderland Medisch Centrum StichtingObesity, Obesity Surgery
Target: 157Updated: 2025-01-17

Phase 4

Effect of Mediterranean diet combined with intermittent fasting on liver fibrosis compared to naltrexone/bupropion (Mysimba) in people with cardiometabolic risk factors
Not yet recruitingCTIS2024-519774-40-00
Sint Franciscus Vlietland Groep Stichtingdislipidaemia or regulated hypertension), or 27 kg/m2 to 30 kg/m2 in the presence of one or more weight-related comorbidities (e.g. type 2 diabetes, People with a Body Mass Index (BMI) of 30 kg/m2 or more (obese)
Target: 70Updated: 2025-10-16